Signature substrate mutations associated with HIV-1 protease inhibitor resistance

被引：0

作者：

Kolli, M. ^{[1
]}

Stawiski, E. ^{[2
]}

Chappey, C. ^{[2
]}

Parkin, N. ^{[2
]}

Schiffer, C. A. ^{[1
]}

机构：

[1] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA

[2] Monogram Biosci Inc, San Francisco, CA USA

来源：

ANTIVIRAL THERAPY | 2007年 / 12卷

关键词：

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：S144 / S144

页数：1

共 50 条

[21] HIV-1 protease inhibitor [J].

Lloyd, AW .

DRUG DISCOVERY TODAY, 1996, 1 (06) :261-261

[22] Combining mutations in HIV-1 protease to understand mechanisms of resistance [J].

Mahalingam, B ;

Boross, P ;

Wang, YF ;

Louis, JM ;

Fischer, CC ;

Tozser, J ;

Harrison, RW ;

Weber, IT .

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2002, 48 (01) :107-116

[23] HIV-1 Protease-Substrate Coevolution in Nelfinavir Resistance [J].

Kolli, Madhavi ;

Ozen, Aysegul ;

Kurt-Yilmaz, Nese ;

Schiffer, Celia A. .

JOURNAL OF VIROLOGY, 2014, 88 (13) :7145-7154

[24] Impact of gag mutations on selection of darunavir resistance mutations in HIV-1 protease [J].

Marcelin, A. G. ;

Lambert-Niclot, S. ;

Canestri, A. ;

Soulie, C. ;

Wirden, M. ;

Tubiana, R. ;

Cheret, A. ;

Katlama, C. ;

Flandre, P. ;

Calvez, V. .

ANTIVIRAL THERAPY, 2008, 13 (04) :A51-A51

[25] Impact of gag mutations on selection of darunavir resistance mutations in HIV-1 protease [J].

Lambert-Niclot, Sidonie ;

Flandre, Philippe ;

Malet, Isabelle ;

Canestri, Ana ;

Soulie, Cathia ;

Tubiana, Roland ;

Brunet, Christel ;

Wirden, Marc ;

Katlama, Christine ;

Calvez, Vincent ;

Marcelin, Anne-Genevieve .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (05) :905-908

[26] HIV-1 envelope facilitates the development of protease inhibitor resistance through acquiring mutations associated with viral entry and immune escape [J].

Maphumulo, Ntombikhona F. ;

Gordon, Michele L. .

FRONTIERS IN MICROBIOLOGY, 2024, 15

[27] Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance [J].

Lataillade, M. ;

Chiarella, J. ;

Kozal, M. J. .

ANTIVIRAL THERAPY, 2006, 11 (05) :S28-S28

[28] Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance [J].

Lataillade, Max ;

Chiarella, Jennifer ;

Kozal, Michael J. .

ANTIVIRAL THERAPY, 2007, 12 (04) :563-570

[29] Predominance of positive epistasis among drug resistance-associated mutations in HIV-1 protease [J].

Zhang, Tian-hao ;

Dai, Lei ;

Barton, John P. ;

Du, Yushen ;

Tan, Yuxiang ;

Pang, Wenwen ;

Chakraborty, Arup K. ;

Lloyd-Smith, James O. ;

Sun, Ren .

PLOS GENETICS, 2020, 16 (10)

[30] The cumulative occurrence of resistance mutations in the HIV-1 protease gene is associated with failure of salvage therapy with ritonavir and saquinavir in protease inhibitor-experienced patients [J].

Karmochkine, M ;

Mohamed, AS ;

Piketty, C ;

Ginsburg, C ;

Raguin, G ;

Schneider-Fauveau, V ;

Gutmann, L ;

Kazatchkine, MD ;

Belec, L .

ANTIVIRAL RESEARCH, 2000, 47 (03) :179-188

← 1 2 3 4 5 →